Perrigo Company Company Profile (NYSE:PRGO)

About Perrigo Company (NYSE:PRGO)

Perrigo Company logoPerrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri. Its businesses include Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, Life Sciences and Other Businesses. The Company offers Healthcare Products across a range of product categories primarily in the United States, the United Kingdom, Mexico, Israel and Australia. In February 2014, the Company announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Related Products
  • Sub-Industry: Pharmaceuticals
  • Symbol: NYSE:PRGO
  • CUSIP: 71429010
  • Web:
  • Market Cap: $12.48 billion
  • Outstanding Shares: 142,611,000
Average Prices:
  • 50 Day Moving Avg: $85.17
  • 200 Day Moving Avg: $75.93
  • 52 Week Range: $63.68 - $92.64
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 17.10
  • P/E Growth: 2.45
Sales & Book Value:
  • Annual Revenue: $5.02 billion
  • Price / Sales: 2.49
  • Book Value: $42.65 per share
  • Price / Book: 2.05
  • Annual Dividend: $0.64
  • Dividend Yield: 0.8%
  • EBITDA: $1.1 billion
  • Net Margins: -51.04%
  • Return on Equity: 11.55%
  • Return on Assets: 5.32%
  • Debt-to-Equity Ratio: 0.54%
  • Current Ratio: 1.73%
  • Quick Ratio: 1.23%
  • Average Volume: 1.55 million shs.
  • Beta: 0.69
  • Short Ratio: 7.3

Frequently Asked Questions for Perrigo Company (NYSE:PRGO)

What is Perrigo Company's stock symbol?

Perrigo Company trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

How often does Perrigo Company pay dividends? What is the dividend yield for Perrigo Company?

Perrigo Company announced a quarterly dividend on Tuesday, August 8th. Shareholders of record on Friday, August 25th will be given a dividend of $0.16 per share on Tuesday, September 12th. This represents a $0.64 dividend on an annualized basis and a yield of 0.73%. The ex-dividend date is Wednesday, August 23rd. View Perrigo Company's Dividend History.

How were Perrigo Company's earnings last quarter?

Perrigo Company (NYSE:PRGO) posted its quarterly earnings data on Thursday, August, 10th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.94 by $0.28. The company had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.18 billion. Perrigo Company had a positive return on equity of 11.55% and a negative net margin of 51.04%. The firm's revenue was down 7.7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.93 EPS. View Perrigo Company's Earnings History.

When will Perrigo Company make its next earnings announcement?

Perrigo Company is scheduled to release their next quarterly earnings announcement on Thursday, November, 9th 2017. View Earnings Estimates for Perrigo Company.

What guidance has Perrigo Company issued on next quarter's earnings?

Perrigo Company issued an update on its FY17 earnings guidance on Thursday, August, 10th. The company provided EPS guidance of $4.45-4.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.28.

Where is Perrigo Company's stock going? Where will Perrigo Company's stock price be in 2017?

15 equities research analysts have issued 12 month price objectives for Perrigo Company's shares. Their forecasts range from $64.00 to $125.00. On average, they expect Perrigo Company's share price to reach $87.77 in the next twelve months. View Analyst Ratings for Perrigo Company.

What are analysts saying about Perrigo Company stock?

Here are some recent quotes from research analysts about Perrigo Company stock:

  • 1. Canaccord Genuity analysts commented, "Date and time of first dissemination: May 22, 2017, 23:13 ET Date and time of production: May 22, 2017, 22:26 ET Target Price / Valuation Methodology: Perrigo Company – PRGO Discounted cash flow analysis supports an $86 valuation for PRGO shares Our discounted cash flow (DCF) analysis leads us to a price target of $86/share for PRGO. Our DCF considers our estimates through 2021, low-single-digit growth through 2033 and zero terminal growth thereafter. In addition, we expect Perrigo’s margin structure to remain somewhat consistent with our 2021 estimates." (5/22/2017)
  • 2. Deutsche Bank AG analysts commented, "We updated our model to reflect PRGO's divestiture of the Tysabri royalty stream to Royalty Pharma, which the company expects to complete this month, and preliminary assumptions for de-leveraging with the proceeds. The net effect of these changes was EPS dilution of ~15-20% over 2017-21 and a reduction in our DCF-derived PT to $87 (from $93), as our prior model reflected more value for the Tysabri royalty stream (~$3bn) relative to the upfront payment of $2.2bn. We have not factored in the potential sales-based milestone payments of $650mn, which could add ~$4/share to the theoretical DCF value if they hit. We continue to view PRGO as a unique asset with good value creation potential over the longer term, and are maintaining our Buy rating. Solid execution in the coming quarters will be critical for the stock, in our view." (3/14/2017)
  • 3. Jefferies Group LLC analysts commented, "Unaudited Q4 results were ahead of forecast. But the real story is FY17 guidance and it disappointed even after sharp cuts to Street models just 4 weeks ago. For the first time we can recall both rev & EPS will decline ' not a good story line for an OTC-focused company. Tysabri's sale helps de-lever PRGO but at the same time shrinks the EPS base by ~$2.20. Mgt continues to make moves to enhance shareholder value ' but it may take quite some time to do so." (2/28/2017)
  • 4. Royal Bank Of Canada analysts commented, "While we expected a challenging 2017 guide, it was worse than we anticipated and came with an unexpected CFO departure. The strategic review around whether to sell Rx/generics will linger, limiting visibility but the conundrum is that we do not see upside in either scenario. We remain on the sidelines with target down to $68. Several additional thoughts after speaking with management this evening." (2/28/2017)

Who are some of Perrigo Company's key competitors?

How do I buy Perrigo Company stock?

Shares of Perrigo Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Perrigo Company's stock price today?

One share of Perrigo Company stock can currently be purchased for approximately $87.53.

MarketBeat Community Rating for Perrigo Company (NYSE PRGO)
Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  489 (Vote Outperform)
Underperform Votes:  479 (Vote Underperform)
Total Votes:  968
MarketBeat's community ratings are surveys of what our community members think about Perrigo Company and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Perrigo Company (NYSE:PRGO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 7 Hold Ratings, 7 Buy Ratings
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $87.77 (0.27% upside)
Consensus Price Target History for Perrigo Company (NYSE:PRGO)
Price Target History for Perrigo Company (NYSE:PRGO)
Analysts' Ratings History for Perrigo Company (NYSE:PRGO)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/2/2017Oppenheimer Holdings, Inc.Initiated CoverageBuy$88.00LowView Rating Details
9/14/2017Deutsche Bank AGBoost Price TargetBuy$88.00 -> $95.00LowView Rating Details
9/13/2017Royal Bank Of CanadaReiterated RatingSell$64.00LowView Rating Details
9/13/2017Canaccord GenuityReiterated RatingBuy$88.00 -> $100.00LowView Rating Details
9/12/2017Cantor FitzgeraldBoost Price TargetOverweight$93.00 -> $107.00LowView Rating Details
9/7/2017CIBCInitiated CoverageOutperform -> Outperform$88.00LowView Rating Details
8/15/2017Wells Fargo & CompanyReiterated RatingMarket Perform$77.00LowView Rating Details
8/11/2017Stifel NicolausReiterated RatingHoldLowView Rating Details
8/11/2017Jefferies Group LLCReiterated RatingHold$69.00 -> $71.00LowView Rating Details
8/11/2017Goldman Sachs Group, Inc. (The)UpgradeSell -> Neutral$66.00 -> $79.00MediumView Rating Details
6/1/2017Barclays PLCReiterated RatingOverweight$100.00 -> $85.00LowView Rating Details
4/22/2017B. RileyReiterated RatingNeutral$67.00MediumView Rating Details
2/28/2017GuggenheimReiterated RatingBuy$125.00N/AView Rating Details
11/10/2016J P Morgan Chase & CoSet Price TargetHold$95.00N/AView Rating Details
11/11/2016Bank of America CorporationUpgradeUnderperform -> NeutralN/AView Rating Details
9/27/2016ArgusReiterated RatingHoldN/AView Rating Details
8/10/2016Leerink SwannSet Price TargetHold$96.00 -> $81.00N/AView Rating Details
8/11/2016Northland SecuritiesDowngradeOutperform -> Market Perform$123.00 -> $94.00N/AView Rating Details
6/17/2016BTIG ResearchReiterated RatingNeutralN/AView Rating Details
6/15/2016Raymond James Financial, Inc.Reiterated RatingHoldN/AView Rating Details
5/14/2016Morgan StanleyReiterated RatingHoldN/AView Rating Details
2/22/2016William BlairReiterated RatingMarket PerformN/AView Rating Details
(Data available from 10/19/2015 forward)


Earnings History for Perrigo Company (NYSE:PRGO)
Earnings by Quarter for Perrigo Company (NYSE:PRGO)
Earnings History by Quarter for Perrigo Company (NYSE PRGO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2017$1.11N/AView Earnings Details
8/10/20176/30/2017$0.94$1.22$1.18 billion$1.24 billionViewN/AView Earnings Details
5/30/2017Q1 17$0.99$1.05$1.19 billion$1.19 billionViewN/AView Earnings Details
5/22/201712/31/2016$1.76$1.24$1.39 billion$1.33 billionViewN/AView Earnings Details
11/10/2016Q316$1.58$1.65$1.28 billion$1.40 billionViewN/AView Earnings Details
8/10/2016Q216$1.98$1.93$1.43 billion$1.48 billionViewListenView Earnings Details
5/12/2016Q116$1.75$1.75$1.35 billion$1.34 billionViewListenView Earnings Details
2/18/2016Q415$1.93$1.80$1.46 billion$1.42 billionViewListenView Earnings Details
10/22/2015Q3$1.73$1.76$1.42 billion$1.34 billionViewListenView Earnings Details
8/5/2015Q2$1.96$2.18$1.52 million$1.53 millionViewN/AView Earnings Details
4/21/2015Q315$1.78$1.85$1.10 billion$1.05 billionViewN/AView Earnings Details
2/5/2015Q215$1.79$1.82$1.09 billion$1.07 billionViewN/AView Earnings Details
11/6/2014Q115$1.44$1.40$997.90 million$951.50 millionViewN/AView Earnings Details
8/14/2014Q414$1.55$1.74$1.09 billion$1.14 billionViewN/AView Earnings Details
5/7/2014Q314$1.51$1.31$1.07 billion$1,000.00 millionViewN/AView Earnings Details
2/6/2014Q214$1.59$1.87$996.68 million$979.00 millionViewN/AView Earnings Details
10/31/2013Q114$1.40$1.52$900.10 million$933.00 millionViewN/AView Earnings Details
8/15/2013Q4 2013$1.56$1.57$999.08 million$967.20 millionViewN/AView Earnings Details
5/7/2013Q3 2013$1.44$1.42$935.44 million$919.83 millionViewN/AView Earnings Details
2/1/2013Q2 2013$1.31$1.36$881.84 million$882.96 millionViewN/AView Earnings Details
11/7/2012Q113$1.24$1.27$825.83 million$769.80 millionViewN/AView Earnings Details
8/16/2012$1.27$1.28ViewN/AView Earnings Details
5/8/2012$1.22$1.41ViewN/AView Earnings Details
2/7/2012$1.15$1.20ViewN/AView Earnings Details
10/27/2011$1.06$1.10ViewN/AView Earnings Details
8/16/2011$0.97$1.02ViewN/AView Earnings Details
5/3/2011$0.97$1.07ViewN/AView Earnings Details
2/1/2011$0.95$1.05ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Perrigo Company (NYSE:PRGO)
Current Year EPS Consensus Estimate: $4.59 EPS
Next Year EPS Consensus Estimate: $5.12 EPS


Current Dividend Information for Perrigo Company (NYSE:PRGO)
Most Recent Dividend:9/12/2017
Annual Dividend:$0.64
Dividend Yield:0.73%
Dividend Growth:17.20% (3 Year Average)
Payout Ratio:-3.51% (Trailing 12 Months of Earnings)
13.94% (Based on This Year's Estimates)
12.50% (Based on Next Year's Estimates)
Track Record:14 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Perrigo Company (NYSE:PRGO)

Dividend History by Quarter for Perrigo Company (NYSE PRGO)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Perrigo Company (NYSE:PRGO)
Insider Ownership Percentage: 6.90%
Institutional Ownership Percentage: 82.44%
Insider Trades by Quarter for Perrigo Company (NYSE:PRGO)
Institutional Ownership by Quarter for Perrigo Company (NYSE:PRGO)
Insider Trades by Quarter for Perrigo Company (NYSE:PRGO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/12/2017Jeffrey NeedhamEVPSell3,595$89.49$321,716.55View SEC Filing  
9/7/2017Sharon KochanEVPSell318$81.36$25,872.48View SEC Filing  
8/31/2017Sharon KochanEVPSell1,500$79.03$118,545.00View SEC Filing  
8/30/2017Thomas FarringtonEVPSell616$76.90$47,370.40View SEC Filing  
8/18/2017Thomas FarringtonEVPSell865$78.40$67,816.00View SEC Filing  
11/25/2016Judy L BrownEVPSell2,097$89.44$187,555.68View SEC Filing  
11/21/2016Geoffrey M ParkerDirectorBuy2,500$88.75$221,875.00View SEC Filing  
10/24/2016Judy L BrownEVPSell2,092$90.42$189,158.64View SEC Filing  
9/26/2016Judy L BrownCFOSell2,096$96.76$202,808.96View SEC Filing  
9/26/2016Thomas FarringtonEVPSell1,110$96.76$107,403.60View SEC Filing  
9/9/2016Gary K Kunkle JrDirectorSell5,814$89.95$522,969.30View SEC Filing  
9/8/2016Herman Morris JrDirectorSell1,073$90.96$97,600.08View SEC Filing  
8/26/2016Judy L BrownEVPSell2,095$88.28$184,946.60View SEC Filing  
4/13/2016Judy L BrownCFOSell2,776$126.22$350,386.72View SEC Filing  
3/18/2016Michael J JandernoaDirectorSell761$128.29$97,628.69View SEC Filing  
3/2/2016Sharon KochanEVPSell1,490$125.28$186,667.20View SEC Filing  
2/24/2016Judy L BrownCFOSell2,776$123.73$343,474.48View SEC Filing  
1/6/2016Judy L. BrownCFOSell27,737$142.41$3,950,026.17View SEC Filing  
12/28/2015Joseph C. PapaChairmanSell10,183$147.07$1,497,613.81View SEC Filing  
8/25/2015John T. HendricksonEVPSell1,737$181.37$315,039.69View SEC Filing  
8/25/2015Todd W. KingmaVPSell1,715$181.37$311,049.55View SEC Filing  
8/24/2015John T. HendricksonEVPSell4,468$177.68$793,874.24View SEC Filing  
4/29/2015Todd W KingmaVPSell1,700$190.27$323,459.00View SEC Filing  
4/14/2015John T HendricksonEVPSell8,800$200.27$1,762,376.00View SEC Filing  
4/13/2015Todd W KingmaVPSell1,300$198.44$257,972.00View SEC Filing  
3/13/2015Jatin ShahSVPSell2,000$165.50$331,000.00View SEC Filing  
10/1/2014Judy L BrownCFOSell3,515$150.72$529,780.80View SEC Filing  
9/3/2014Sharon KochanEVPSell1,116$150.00$167,400.00View SEC Filing  
9/3/2014Todd W KingmaVPSell2,250$149.65$336,712.50View SEC Filing  
9/2/2014Judy L BrownCFOSell3,515$149.32$524,859.80View SEC Filing  
9/2/2014Thomas FarringtonVPSell1,741$150.36$261,776.76View SEC Filing  
8/27/2014Michael Robert StewartVPSell4,519$148.78$672,336.82View SEC Filing  
8/26/2014Jeffrey NeedhamVPSell10,205$148.54$1,515,850.70View SEC Filing  
8/26/2014Judy L BrownCFOSell4,827$148.87$718,595.49View SEC Filing  
8/25/2014John T HendricksonEVPSell2,533$148.44$375,998.52View SEC Filing  
5/15/2014Ran GottfriedDirectorSell1,000$131.25$131,250.00View SEC Filing  
3/24/2014Joseph PapaChairmanSell10,000$157.72$1,577,200.00View SEC Filing  
1/16/2014Joseph PapaChairmanSell5,000$157.59$787,950.00View SEC Filing  
12/12/2013Gary CohenDirectorSell4,632$152.52$706,472.64View SEC Filing  
12/12/2013Joseph PapaChairmanSell15,000$150.12$2,251,800.00View SEC Filing  
12/9/2013Michael JandernoaDirectorSell128,620$155.30$19,974,686.00View SEC Filing  
11/25/2013Louis YuVPSell2,292$155.51$356,428.92View SEC Filing  
11/21/2013Judy BrownCFOSell9,988$154.74$1,545,543.12View SEC Filing  
11/20/2013John HendricksonEVPSell8,400$152.80$1,283,520.00View SEC Filing  
11/4/2013Ran GottfriedDirectorSell2,275$143.36$326,144.00View SEC Filing  
9/24/2013Joseph PapaChairmanSell15,000$124.60$1,869,000.00View SEC Filing  
9/18/2013John HendricksonEVPSell2,161$125.00$270,125.00View SEC Filing  
9/11/2013Michael Robert StewartVPSell5,063$123.37$624,622.31View SEC Filing  
9/9/2013Louis YuVPSell1,852$124.11$229,851.72View SEC Filing  
9/6/2013John T HendricksonEVPSell1,000$123.46$123,460.00View SEC Filing  
9/4/2013John T HendricksonEVPSell2,000$123.92$247,840.00View SEC Filing  
9/3/2013Judy BrownCFOSell2,500$122.07$305,175.00View SEC Filing  
8/30/2013Jeffrey NeedhamVPSell6,585$120.47$793,294.95View SEC Filing  
8/29/2013Sharon KochanVPSell3,467$120.98$419,437.66View SEC Filing  
8/27/2013Joseph PapaChairmanSell15,000$117.64$1,764,600.00View SEC Filing  
8/26/2013John HendricksonEVPSell2,099$119.15$250,095.85View SEC Filing  
8/26/2013Judy BrownCFOSell3,424$119.28$408,414.72View SEC Filing  
8/20/2013John HendricksonEVPSell1,676$118.56$198,706.56View SEC Filing  
8/20/2013Judy BrownCFOSell2,804$118.58$332,498.32View SEC Filing  
8/20/2013Thomas FarringtonVPSell1,658$119.86$198,727.88View SEC Filing  
8/16/2013Todd KingmaVPSell1,250$120.00$150,000.00View SEC Filing  
7/19/2013Todd W KingmaVPSell1,250$129.37$161,712.50View SEC Filing  
7/11/2013Joseph C PapaChairmanSell10,000$128.54$1,285,400.00View SEC Filing  
7/9/2013John T HendricksonEVPSell2,161$125.00$270,125.00View SEC Filing  
6/14/2013Joseph C PapaChairmanSell10,000$118.39$1,183,900.00View SEC Filing  
6/14/2013Todd W KingmaVPSell1,250$118.00$147,500.00View SEC Filing  
6/4/2013Judy L BrownCFOSell2,500$116.38$290,950.00View SEC Filing  
5/14/2013Sharon KochanVPSell2,647$119.64$316,687.08View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Perrigo Company (NYSE:PRGO)
Latest Headlines for Perrigo Company (NYSE:PRGO)
DateHeadline logoPRGO Crosses Above Average Analyst Target - October 19 at 7:43 AM logo Brokerages Expect Perrigo Company (PRGO) Will Post Quarterly Sales of $1.17 Billion - October 17 at 8:02 AM logo$1.17 Billion in Sales Expected for Perrigo Company (PRGO) This Quarter - October 17 at 8:02 AM logoZacks: Analysts Anticipate Perrigo Company (PRGO) to Announce $1.12 Earnings Per Share - October 15 at 8:30 AM logoPres Trump believes he has the cure for Obamacare - October 15 at 6:12 AM logoPerrigo Sees IBD RS Rating Improve To 73 - October 12 at 8:27 AM logoPerrigo Co. (PRGO) PT Raised to $98 at UBS After Updating Estimates - - October 5 at 5:28 PM logoPerrigo's (PRGO) "Buy" Rating Reiterated at UBS AG - October 5 at 10:08 AM logoEvening Sector Snapshot: Pharmaceuticals Gain, Aluminum Slips - October 3 at 11:03 AM logoPerrigo Company (PRGO) Research Coverage Started at Oppenheimer Holdings, Inc. - October 2 at 4:30 PM logoPerrigo Company (PRGO) Receives Average Rating of "Hold" from Analysts - September 30 at 3:10 PM logoPerrigo (PRGO) Announces First-To-Market Launch of OTC Store Brand Equivalent of Nexium 24HR Capsules - - September 29 at 6:14 PM logoPerrigo Announces First-To-Market Launch Of The OTC Store Brand Equivalent Of Nexium® 24HR Capsules - September 28 at 1:26 AM logoPerrigo (PRGO) Announces First-To-Market Launch of OTC Store Brand Equivalent of Nexium 24HR Capsules - September 27 at 4:22 PM logo Analysts Expect Perrigo Company (PRGO) to Announce $1.11 EPS - September 26 at 12:28 PM logoPerrigo:FDA Oks AB Rated Generic Version Of Exalgo 32mg Extended Release Tablets - September 22 at 2:08 PM logoPerrigo Announces FDA Final Approval For Its AB Rated Generic Version Of Exalgo® 32mg Extended Release Tablets - September 22 at 2:08 PM logoJeffery Smith's best idea - September 20 at 7:55 AM logoFDA tentatively OKs Perrigo's generic Acanya - September 19 at 6:41 AM logoPerrigo Announces Tentative FDA Approval For The Generic Version Of Acanya® Gel - September 19 at 6:41 AM logoPerrigo says the FDA has given tentative approval to generic acne gel - September 19 at 6:41 AM logoPerrigo Scores Relative Strength Rating Upgrade; Hits Key Threshold - September 15 at 7:46 AM logoPerrigo Company (PRGO) EVP Sells $321,716.55 in Stock - September 14 at 11:16 PM logoDeutsche Bank AG Increases Perrigo Company (PRGO) Price Target to $95.00 - September 14 at 1:40 PM logoPerrigo Company Reaches Analyst Target Price - Nasdaq - September 14 at 9:25 AM logoETFs with exposure to Perrigo Co. Plc : September 13, 2017 - September 14 at 9:25 AM logoRoyal Bank Of Canada Reaffirms "Sell" Rating for Perrigo Company (PRGO) - September 13 at 9:44 PM logoCanaccord Genuity Reiterates "Buy" Rating for Perrigo Company (PRGO) - September 13 at 8:36 AM logoPerrigo Co. (PRGO) PT Raised to $107 at Cantor Fitzgerald Following Meetings with CEO & CFO: Upside Potential to ... - - September 13 at 7:57 AM logoPerrigo Co. (PRGO) PT Raised to $100 at Canaccord Genuity Following Meeting With Management - - September 13 at 7:57 AM logoPerrigo Company plc (PRGO) PT Raised to $107.00 at Cantor Fitzgerald - September 12 at 7:36 PM logoStarboard likes Perrigo, undervalued despite strong OTC business; shares up 4% - September 12 at 3:51 PM logoStarboard Value CEO Smith pushes Perrigo, Altaba as best ideas - September 12 at 12:31 PM logoTeva’s stock rockets to biggest gain since 1984 - September 12 at 8:50 AM logoTeva’s stock rockets to biggest gain since 1984 - September 12 at 8:50 AM logoPerrigo Co. Plc :PRGO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017 - September 12 at 8:49 AM logoPerrigo Company (PRGO) EVP Sharon Kochan Sells 318 Shares - September 11 at 8:22 PM logoPerrigo Company (PRGO) Expected to Announce Quarterly Sales of $1.17 Billion - September 9 at 6:46 AM logoThursday Sector Leaders: Healthcare, Utilities - September 7 at 9:38 PM logoEvening Sector Snapshot: Pharmaceuticals Climb, Disney Falls - September 7 at 9:38 PM logo$1.11 Earnings Per Share Expected for Perrigo Company (PRGO) This Quarter - September 7 at 8:26 PM logoUPDATE: Oppenheimer Starts Perrigo Co. (PRGO) at Outperform - - September 7 at 4:35 PM logoCIBC Begins Coverage on Perrigo Company (PRGO) - September 7 at 2:16 PM logoOppenheimer Holdings, Inc. Initiates Coverage on Perrigo Company (PRGO) - September 7 at 11:01 AM logoPerrigo Company (PRGO) EVP Sells $118,545.00 in Stock - September 5 at 4:28 PM logoPerrigo Company (PRGO) Given Consensus Rating of "Hold" by Brokerages - September 5 at 2:58 PM logoPerrigo Company (PRGO) EVP Thomas Farrington Sells 616 Shares - September 1 at 4:40 PM logoPerrigo Company To Present At Upcoming Investor Conferences - August 31 at 8:55 AM logoTracking Ruane, Cunniff, & Goldfarb's Portfolio - Q2 2017 Update - Seeking Alpha - August 23 at 8:54 AM logoPerrigo Company (PRGO) EVP Thomas Farrington Sells 865 Shares - August 22 at 7:56 PM



Perrigo Company (PRGO) Chart for Thursday, October, 19, 2017

This page was last updated on 10/19/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.